Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Free Cash Flow (2016 - 2025)

Sunshine Biopharma (SBFM) has disclosed Free Cash Flow for 14 consecutive years, with -$735840.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Free Cash Flow rose 60.73% year-over-year to -$735840.0, compared with a TTM value of -$7.4 million through Sep 2025, up 42.96%, and an annual FY2024 reading of -$14.2 million, down 60.19% over the prior year.
  • Free Cash Flow was -$735840.0 for Q3 2025 at Sunshine Biopharma, up from -$1.4 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$297355.0 in Q1 2021 and bottomed at -$5.6 million in Q2 2024.
  • Average Free Cash Flow over 5 years is -$1.8 million, with a median of -$1.4 million recorded in 2025.
  • The sharpest move saw Free Cash Flow crashed 858.16% in 2021, then skyrocketed 74.18% in 2025.
  • Year by year, Free Cash Flow stood at -$312113.0 in 2021, then plummeted by 681.96% to -$2.4 million in 2022, then rose by 5.46% to -$2.3 million in 2023, then plummeted by 52.31% to -$3.5 million in 2024, then surged by 79.06% to -$735840.0 in 2025.
  • Business Quant data shows Free Cash Flow for SBFM at -$735840.0 in Q3 2025, -$1.4 million in Q2 2025, and -$1.7 million in Q1 2025.